APA (7th ed.) Citation

Bresser, H., Schmoor, C., Grishina, O., Pfeifer, D., Thomas, J., Rehman, U., . . . de Wit, M. (2025). Impact of TP53 Mutation Status in Elderly AML Patients When Adding All‐Trans Retinoic Acid or Valproic Acid to Decitabine. European Journal of Haematology, 114(2), 231. https://doi.org/10.1111/ejh.14304

Chicago Style (17th ed.) Citation

Bresser, Helena, et al. "Impact of TP53 Mutation Status in Elderly AML Patients When Adding All‐Trans Retinoic Acid or Valproic Acid to Decitabine." European Journal of Haematology 114, no. 2 (2025): 231. https://doi.org/10.1111/ejh.14304.

MLA (9th ed.) Citation

Bresser, Helena, et al. "Impact of TP53 Mutation Status in Elderly AML Patients When Adding All‐Trans Retinoic Acid or Valproic Acid to Decitabine." European Journal of Haematology, vol. 114, no. 2, 2025, p. 231, https://doi.org/10.1111/ejh.14304.